---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-022404"
form_type: "8-K"
ticker: "KVAC"
cik: "0001889983"
company_name: "Keen Vision Acquisition Corp."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:48:07.608714+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Keen Vision Acquisition enters binding LOI for $100M merger with Novoheart

## Summary
- LOI replaces prior Sept 2024 Merger Agreement, which was terminated via mutual release.
- Agreed enterprise valuation of Novoheart at $100M; required closing liquidity ≥$10M.
- Cash expense caps: Parent $700K, NVH $1.3M; PIPE fundraising must close within 9 months.
- Parties to negotiate replacement merger agreement by April 10, 2026; conditions consistent with prior agreement.
- Medera China subsidiaries excluded from the business combination.

## SEC filing metadata
- accession: 0001213900-26-022404
- form_type: 8-K
- ticker: KVAC
- cik: 0001889983
- company_name: Keen Vision Acquisition Corp.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1889983/000121390026022404/0001213900-26-022404-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1889983/000121390026022404/ea0279210-8k_keen.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-022404
- JSON: https://secwatch.observer/filing/0001213900-26-022404.json
- Plain text: https://secwatch.observer/filing/0001213900-26-022404.txt

## Key facts
- Material Agreements
  Keen Vision Acquisition Corp. entered into Binding Letter of Intent with Medera Inc. and Novoheart Group Limited valued at Enterprise valuation of Novoheart Group Limited set at US$100,000,000; surviving company must have a (effective 2026-02-26).
  - Action: entry
  - Agreement: merger
  - Counterparty: Medera Inc. and Novoheart Group Limited
  - Value: Enterprise valuation of Novoheart Group Limited set at US$100,000,000; surviving company must have a
  - Effective: 2026-02-26
  source text: On February 26, 2026, Keen Vision Acquisition Corporation, a British Virgin Islands business company limited by shares (“Parent”), entered into a binding letter of intent (“LOI”) with Medera Inc., a Cayman Islands exempted company (“Company”), and Novoheart Group Limited, a British Virgin Islands company and wholly owned subsidiary of the Company (“NVH”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1889983/000121390026022404/0001213900-26-022404-index.htm
- Material Agreements
  Keen Vision Acquisition Corp. terminated Prior Merger Agreement with Medera Inc. and Novoheart Group Limited valued at Prior Merger Agreement dated September 3, 2024 was terminated concurrently with execution of the LOI (effective 2026-02-26).
  - Action: termination
  - Agreement: merger
  - Counterparty: Medera Inc. and Novoheart Group Limited
  - Value: Prior Merger Agreement dated September 3, 2024 was terminated concurrently with execution of the LOI
  - Effective: 2026-02-26
  source text: The LOI replaces the prior Merger Agreement dated September 3, 2024, which was terminated concurrently with execution of the LOI pursuant to a mutual release agreement entered into by the parties.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1889983/000121390026022404/0001213900-26-022404-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.